An Open-Label, Multicenter Extension Study of Trastuzum

Project: Research project

Project Details

Description

An open label multicenter extension study of Trastuzumab-mcc dm1 (TDM1)administered as a single agent or in combination with other anti-cancer therapies in patients previously treated with the equivalent TDM1 regimen
StatusFinished
Effective start/end date8/30/111/20/16

Funding

  • Genentech Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.